Novo Nordisk Shares Drop 8% Despite Ambitious Sales Target for Obesity Drugs
Novo Nordisk's stock fell by 8.1% after the company announced a $23 billion sales target for its obe…
Novo Nordisk's stock fell by 8.1% after the company announced a $23 billion sales target for its obe…